Haemophilus influenzae type b vaccine and whole cell DTP vaccine
Trade name: Tetramune
Vaccineapproved
Approved
Mar 1, 1993
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1990s
- Mar 1, 1993
Earliest FDA Approval
Indications
Mechanism of action
- Bordetella pertussisImmunity, active
Bordetella pertussis immunity, active
- Clostridium tetaniImmunity, active
Clostridium tetani immunity, active
- Haemophilus influenzaeImmunity, active
Haemophilus influenzae immunity, active
- Corynebacterium diphtheriaeImmunity, active
Corynebacterium diphtheriae immunity, active
Approval history
- approvedMar 1, 1993
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No